Claims
- 1. A high growth methanotrophic bacterial strain which:
(a) grows on a C1 carbon substrate selected from the group consisting of methane and methanol; and (b) comprises a functional Embden-Meyerhof carbon pathway, said pathway comprising a gene encoding a pyrophosphate dependent phosphofructokinase enzyme, the gene selected from the group consisting of:
(a) an isolated nucleic acid molecule encoding the amino acid sequence as set forth in SEQ ID NO:6; (b) an isolated nucleic acid molecule that hybridizes with (a) under the following hybridization conditions: 0.1×SSC, 0.1% SDS, 65° C. and washed with 2×SSC, 0.1% SDS followed by 0.1×SSC, 0.1% SDS; (c) an isolated nucleic acid molecule comprising a first nucleotide sequence encoding a polypeptide of at least 437 amino acids that has at least 63% identity based on the Smith-Waterman method of alignment when compared to a polypeptide having the sequence as set forth in SEQ ID NO:6; and (d) an isolated nucleic acid molecule that is complementary to (a), (b) or (c).
- 2. A high growth methanotrophic bacterial strain according to claim 1 wherein the strain optionally contains a functional Entner-Douderoff carbon pathway.
- 3. A bacterial strain according to claim 1 having at least one gene encoding a fructose bisphosphate aldolase enzyme.
- 4. A bacterial strain according to claim 3 wherein at least one gene encodes a fructose bisphosphate aldolase enzyme having the amino acid sequence selected from the group consisting of SEQ ID NO:16 and SEQ ID NO:18.
- 5. A bacterial strain according to claim 2 having at least one gene encoding a keto-deoxy phosphogluconate aldolase.
- 6. A bacterial strain according to claim 5 wherein at least one gene encodes a keto-deoxy phosphogluconate aldolase enzyme is selected from the group consisting of:
(a) an isolated nucleic acid molecule encoding the amino acid sequence as set forth in SEQ ID NO:20; (b) an isolated nucleic acid molecule that hybridizes with (a) under the following hybridization conditions: 0.1×SSC, 0.1% SDS, 65° C. and washed with 2×SSC, 0.1% SDS followed by 0.1×SSC, 0.1% SDS; (c) an isolated nucleic acid molecule comprising a first nucleotide sequence encoding a polypeptide of at least 212 amino acids that has at least 59% identity based on the Smith-Waterman method of alignment when compared to a polypeptide having the sequence as set forth in SEQ ID NO:20; and (d) an isolated nucleic acid molecule that is complementary to (a), (b) or (c).
- 7. A bacterial strain according to any of claims 1 or 2 having a gene encoding a polypeptide involved in carbon flux wherein the polypeptide is selected from the group consisting of SEQ ID NO:2, 4, 6, 8, 10, 12, 14, 16, 18 and 20.
- 8. A bacterial strain according to any of claims 1 or 2 optionally comprising a denitrifying enzymatic pathway.
- 9. The bacterial strain of claim 8 wherein the enzymes of the denitrifying pathway are polypeptides having the amino acid sequences selected from the group consisting of SEQ ID NO:40, 42, 44, 46, 48, 50, 52, 54, 56, 58 and 60.
- 10. The bacterial strain of any of claims 1 or 2 having genes encoding exopolysaccharide synthesizing enzymes, the enzymes selected from the group consisting of SEQ ID NO:22, 24, 26, 28, 30, 32, 34, 36, and 38.
- 11. The bacterial strain of any of claims 1 or 2 having genes encoding isoprenoid synthesizing enzymes, the enzymes selected from the group consisting of SEQ ID NO:62, 64, 66, 68, 70, 72, 74, 86, and 78.
- 12. The bacterial strain of claim 1 wherein the strain is a Methylomonas sp.
- 13. The bacterial strain of claim 12 having a 16s RNA profile as set forth in SEQ ID NO:81.
- 14. The bacterial strain of claim 1 wherein, when the C1 carbon substrate is methanol, the strain produces glycogen comprising at least about 50% dry weight of biomass.
- 15 The bacterial strain of either claim 1 or claim 14 wherein the methanol concentration in the medium is about 2.5% (vol/vol).
- 16. The bacterial strain of any of claims 1 or 2 having a yield of greater than 1.0 grams of cell mass per gram of methane consumed.
- 17. The bacterial strain of any of claims 1 or 2 having a yield of greater than 0.5 grams of cell mass per gram of methane consumed.
- 18. The bacterial strain of any of claims 1 or 2 having a carbon conversion efficiency of greater than 40 g/mol methane/g/mol biomass.
- 19. The bacterial strain of any of claims 1 or 2 having a carbon conversion efficiency of greater than 65 g/mol methane/g/mol biomass.
- 20. The bacterial strain of any of claims 1 or 2 having a carbon conversion efficiency of greater than 70 g/mol methane/g/mol biomass.
- 21. A high growth methanotrophic bacterial strain which grows on a C1 carbon substrate selected from the group consisting of methanol and methane, comprising the 16s RNA sequence as set forth in SEQ ID NO:81 and having at least one gene encoding a pyrophosphate dependent Phosphofructokinase enzyme.
- 22. A high growth methanotrophic bacterial strain according to claim 20 optionally having at least one gene encoding a keto-deoxy phosphogluconate aldolase.
- 23. A high growth methanotrophic bacterial strain having the ATCC designation PTA 2402.
- 24. A method for the production of single cell protein comprising:
a) contacting the bacterial strains of any of the claims 1, 2, 3, 5, or 18 with C1 carbon substrate, selected from the group consisting of methane and methanol, in a suitable medium for a time sufficient to permit the expression and accumulation of single cell protein; and b) optionally recovering the single cell protein.
- 25. The method of claim 23 wherein the C1 carbon substrate is contacted with the bacterial strain under anaerobic conditions.
- 26. The method of claim 23 wherein the C1 carbon substrate is contacted with the bacterial strain under aerobic conditions.
- 27. A method for the biotransformation of a nitrogen containing compound selected from the group consisting of ammonia, nitrate, nitrite, and dinitrogen, comprising contacting the bacterial strain of any of the claims 8 or 9 with a C1 carbon substrate selected from the group consisting of methane or methanol, in the presence of the nitrogen containing compound, in a suitable medium for a time sufficient to permit the biotransformation of the nitrogen containing compound.
- 28. A method for the production of a feed product comprising protein, carbohydrates and pigment comprising the steps of:
a) contacting the bacterial strain of any of claims 1, 2, 3, 5 or 18 with a C1 carbon substrate in a suitable medium for a time sufficient to permit the expression and accumulation of the feed product; and b) optionally recovering the feed product.
- 29. A method according to claim 28 wherein the relative compositions of protein, carbohydrate and pigment are altered through the up-regulation or down-regulation of any one of the genes encoding the proteins selected from the group consisting of SEQ ID NO:1, 3, 5, 7, 9, 11, 13, 15, 17, 19, 21, 23, 25, 27, 29, 31, 33, 35, 37, 39, 41, 43, 45, 47, 49, 51, 53, 55, 57, 59, 61, 63, 65, 67, and 69.
- 30. A method of identifying the high growth methanotrophic bacterial strain of claim 1 comprising:
(a) growing a sample suspected of containing a high growth methanotrophic bacterial strain on a suitable growth medium in the presence of methane as a sole carbon source; (b) identifying colonies that grow on the conditions of step (a); (c) analyzing the colonies identified in step (b) for the presence of pyrophosphate dependent phosphofructokinase activity.
- 31. A method according to claim 30 wherein the colonies of step (b) are additionally analyzed for the presence of a gene selected from the group consisting of:
(a) an isolated nucleic acid molecule encoding the amino acid sequence as set forth in SEQ ID NO:6; (b) an isolated nucleic acid molecule that hybridizes with (a) under the following hybridization conditions: 0.1×SSC, 0.1% SDS, 65° C. and washed with 2×SSC, 0.1% SDS followed by 0.1×SSC, 0.1% SDS; (c) an isolated nucleic acid molecule comprising a first nucleotide sequence encoding a polypeptide of at least 437 amino acids that has at least 63% identity based on the Smith-Waterman method of alignment when compared to a polypeptide having the sequence as set forth in SEQ ID NO:6; and (d) an isolated nucleic acid molecule that is complementary to (a), (b) or (c).
Parent Case Info
[0001] This application claims the benefit of U.S. Provisional Application No. 60/229,858 filed Sep. 1, 2000.
Provisional Applications (1)
|
Number |
Date |
Country |
|
60229858 |
Sep 2000 |
US |